Improving Druggability of Novel Diarylpyrimidine NNRTIs by a Fragment-Based Replacement Strategy: From Biphenyl-DAPYs to Heteroaromatic-Biphenyl-DAPYs
出版年份 2021 全文链接
标题
Improving Druggability of Novel Diarylpyrimidine NNRTIs by a Fragment-Based Replacement Strategy: From Biphenyl-DAPYs to Heteroaromatic-Biphenyl-DAPYs
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 14, Pages 10297-10311
出版商
American Chemical Society (ACS)
发表日期
2021-07-02
DOI
10.1021/acs.jmedchem.1c00708
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Druggability modification strategies of the diarylpyrimidine‐type non‐nucleoside reverse transcriptase inhibitors
- (2021) Li Ding et al. MEDICINAL RESEARCH REVIEWS
- Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors
- (2021) Helen E. Aylott et al. JOURNAL OF MEDICINAL CHEMISTRY
- 2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies
- (2021) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hydrophobic Pocket Occupation Design of Difluoro-Biphenyl-Diarylpyrimidines as Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors: from N-Alkylation to Methyl Hopping on the Pyrimidine Ring
- (2021) Li Ding et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy
- (2021) Jing Zhu et al. Acta Pharmaceutica Sinica B
- Pharmacophore-fusing design of pyrimidine sulfonylacetanilides as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase
- (2020) Yali Sang et al. BIOORGANIC CHEMISTRY
- Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel
- (2020) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design of Biphenyl-Substituted Diarylpyrimidines with a Cyanomethyl Linker as HIV-1 NNRTIs via a Molecular Hybridization Strategy
- (2020) Yuan Lei et al. MOLECULES
- Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties
- (2020) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Scaffold Hopping in Discovery of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: From CH(CN)-DABOs to CH(CN)-DAPYs
- (2020) Ting-Ting Li et al. MOLECULES
- Privileged scaffold inspired design of novel oxime-biphenyl-DAPYs in treatment of HIV-1
- (2020) Yang Yang et al. BIOORGANIC CHEMISTRY
- Structure–Activity Relationship Exploration of NNIBP Tolerant Region I Leads to Potent HIV-1 NNRTIs
- (2020) Dongwei Kang et al. ACS Infectious Diseases
- Radiosensitization of human pancreatic cancer by piperlongumine analogues
- (2020) Hao Ma et al. CHINESE CHEMICAL LETTERS
- Bioisosterism-based design and enantiomeric profiling of chiral hydroxyl-substituted biphenyl-diarylpyrimidine nonnucleoside HIV-1 reverse transcriptase inhibitors
- (2020) Xiaomei Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Neuroprotective Effect of Swertiamain on Cerebral Ischemia/Reperfusion Injury by Inducing the Nrf2 Protective Pathway
- (2019) Hui Wang et al. ACS Chemical Neuroscience
- Follow on-based optimization of the biphenyl-DAPYs as HIV-1 nonnucleoside reverse transcriptase inhibitors against the wild-type and mutant strains
- (2019) Yali Sang et al. BIOORGANIC CHEMISTRY
- Fragment-based discovery of sulfur-containing diarylbenzopyrimidines as novel nonnucleoside reverse transcriptase inhibitors
- (2019) Sheng Han et al. CHINESE CHEMICAL LETTERS
- Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic Profiles
- (2019) Sheng Han et al. ACS Infectious Diseases
- Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
- (2019) Kaijun Jin et al. Acta Pharmaceutica Sinica B
- Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): Our past twenty years
- (2019) Chunlin Zhuang et al. Acta Pharmaceutica Sinica B
- Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic Profiles
- (2019) Yali Sang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1
- (2018) KaiJun Jin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Structure–Activity Relationship (SAR) Studies of Novel Pyrazolopyridine Derivatives as Inhibitors of Enterovirus Replication
- (2018) Yanpeng Xing et al. JOURNAL OF MEDICINAL CHEMISTRY
- Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors
- (2018) Shuang-Xi Gu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Rapid Identification of Keap1–Nrf2 Small-Molecule Inhibitors through Structure-Based Virtual Screening and Hit-Based Substructure Search
- (2014) Chunlin Zhuang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
- (2014) Edon Vitaku et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mitigating Heterocycle Metabolism in Drug Discovery
- (2012) David J. St. Jean et al. JOURNAL OF MEDICINAL CHEMISTRY
- Strategies and Chemical Design Approaches to Reduce the Potential for Formation of Reactive Metabolic Species
- (2011) Upendra A. Argikar et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
- (2011) Nicholas A. Meanwell JOURNAL OF MEDICINAL CHEMISTRY
- Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 5. An Evolution from Indole to Azaindoles Leading to the Discovery of 1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a Drug Candidate That Demonstrates Antiviral Activity in HIV-1-Infected Subjects∞
- (2009) Tao Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later
- (2008) Christophe Pannecouque et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started